Literature DB >> 18618372

Incidence of enteropathy--associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands.

Wieke H M Verbeek1, Jolanda M W Van De Water, Abdulbaqi Al-Toma, Joost J Oudejans, Chris J J Mulder, Veerle M H Coupé.   

Abstract

OBJECTIVE: Enteropathy-associated T-cell lymphomas (EATLs) are T-cell non-Hodgkin lymphomas of the small bowel, which are specifically associated with coeliac disease (CD). To our knowledge no studies have previously reported on the overall incidence of EATLs in the general population. The aim of this study was to investigate the incidence of EATL and the demographic characteristics of patients with EATL in The Netherlands.
MATERIAL AND METHODS: A survey of the nation-wide network and registry of histo- and cytopathology reports in The Netherlands (PALGA) was performed. We included all T-cell lymphomas detected between January 2000 and December 2006 that initially presented in the small bowel. Crude and world standardized incidence rates were computed as well as gender- and age-specific incidence rates. Finally, the distribution of characteristics such as the localization, the Marsh classification and method of diagnosis are described.
RESULTS: Clinicopathological data were gathered for 116 cases of EATL. The mean age at primary presentation of EATL was 64 years. The crude incidence in the total Dutch population was 0.10/100,000 with an incidence of 2.08/100,000 in the over 50-year-olds. Age-specific incidences were 1.44/100,000 in the 50-59 years age group, 2.92/100,000 in the 60-69 years age group, and 2.53/100,000 in the 70-79 years age group. There was a significant predominance of males (64%, p=0.004, CI 54-72); above the age of 50 the gender-specific incidence was 2.95/100,000 in males versus 1.09/100,000 in females. Most EATLs were localized in the proximal small intestine and the diagnosis was made by surgical resection in the majority of cases.
CONCLUSIONS: EATL is a rare disease with an incidence of 0.10 per 100,000 inhabitants per year, occurring in older age, with a peak incidence in the 7th decade. The tumour is mainly localized in the proximal small intestine. Although uncomplicated CD is twice as frequent in female patients, EATL is more prevalent in males.

Entities:  

Mesh:

Year:  2008        PMID: 18618372     DOI: 10.1080/00365520802240222

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  27 in total

1.  Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.

Authors:  Reem Z Sharaiha; Ben Lebwohl; Laura Reimers; Govind Bhagat; Peter H Green; Alfred I Neugut
Journal:  Cancer       Date:  2011-12-13       Impact factor: 6.860

Review 2.  Enteropathy-associated T cell lymphoma presenting with acute abdominal syndrome: a case report and review of literature.

Authors:  Yifan Yang; Sukhjeet S Batth; Mingyi Chen; Dariusz Borys; Ho Phan
Journal:  J Gastrointest Surg       Date:  2012-04-12       Impact factor: 3.452

3.  Early radiological findings on CT in a patient with enteropathy-associated T cell lymphoma.

Authors:  Kota Sato; Michihiro Uchiyama
Journal:  BMJ Case Rep       Date:  2011-12-21

Review 4.  Classification and management of refractory coeliac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

5.  Enteropathy associated T cell lymphoma: common in coeliac disease.

Authors:  Gabrielle Christina Colleran; Kevin Christopher Cronin; Mary Casey; Fadel Bennani; Iqdam Tobbia; Kevin Barry
Journal:  BMJ Case Rep       Date:  2009-02-23

Review 6.  Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.

Authors:  Michal K Sieniawski; Anne L Lennard
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

Review 7.  Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review.

Authors:  Waseem Lone; Aisha Alkhiniji; Jayadev Manikkam Umakanthan; Javeed Iqbal
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

Review 8.  Refractory celiac disease: from bench to bedside.

Authors:  Georgia Malamut; Bertrand Meresse; Christophe Cellier; Nadine Cerf-Bensussan
Journal:  Semin Immunopathol       Date:  2012-07-19       Impact factor: 9.623

9.  Adult celiac disease and its malignant complications.

Authors:  Hugh J Freeman
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

10.  Diagnosis and treatment of coeliac disease.

Authors:  Karel Geboes; Karen P Geboes
Journal:  F1000 Med Rep       Date:  2009-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.